Insight Molecular Diagnostics, Inc. (IMDX)
6.41
-0.01
(-0.16%)
USD |
NASDAQ |
May 15, 16:00
6.48
+0.07
(+1.09%)
Pre-Market: 20:00
Insight Molecular Diagnostics Profit Margin (Quarterly) : -13.41K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Veracyte, Inc. | 20.64% |
| Exagen, Inc. | -22.92% |
| bioAffinity Technologies, Inc. | -268.6% |
| GRAIL, Inc. | -228.5% |
| FONAR Corp. | 8.79% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -108.2% |
| Gross Profit Margin (Quarterly) | -1.89K% |
| Operating Margin (Quarterly) | -32.28K% |
| Return on Net Operating Assets | -264.7% |